Related by context. All words. (Click for frequent words.) 70 Rosuvastatin 62 Decompensated Heart Failure 61 Treating Chronic 61 Prospective Randomized 61 Invasive Fungal Infections 60 venous thromboembolic disease 60 Venous Thromboembolism 60 Intervention Effectiveness 60 Hospital Acquired Pneumonia 59 See CLINICAL PHARMACOLOGY 59 Cholesterol Levels SPARCL 59 Carotid Revascularization Endarterectomy vs. 59 Demonstrates Efficacy 59 Study Shows Promise 59 Catheter Associated 59 Metastatic Prostate Cancer 59 Treatment Reduces 59 Fondaparinux 59 Percutaneous Coronary Intervention 59 Patients Receiving 59 JUPITER Justification 59 Clostridium difficile Infection 58 Fungal Infections 58 ExTRACT TIMI 58 Antihypertensive 58 Bone Metabolism 58 STRIDE PD 58 number NCT# ClinicalTrials.gov 58 Reduces Mortality 58 Aggressive Reduction 58 American Migraine Prevalence 58 Shows Efficacy 58 AA Amyloidosis 58 Lipid Lowering Treatment 57 Colorectal Adenomas 57 Prospective Multicenter 57 Kidney Function 57 Anticoagulant 57 Septic Shock 57 Recurrent Stroke 57 Bronchopulmonary Dysplasia 57 Myocardial Ischemia 57 Adjunctive 57 Bicalutamide 57 Shown Effective 57 Clinical Outcome 57 Kidney Transplant Patients 57 acute onset CINV 56 Drug Prevents 56 Bone Fractures 56 Known generically 56 thrombin inhibiting aptamer 56 Osteoarthritis Patients 56 leukotriene receptor antagonists 56 Cardiovascular Outcomes 56 Meta Analysis 56 Randomized Phase 56 Platelet Inhibition 56 Ranolazine 56 Randomized Controlled Trial 56 Surgical Treatment 56 Asthma COPD 56 Menopausal Symptoms 56 Ischaemic 56 Osteoporosis Treatment 56 SPARCL 56 Acute Ischemic Stroke 56 inhaled corticosteroid ICS 56 Antithrombotic 56 #:#-#,# Medline 56 Systematic Review 56 pioglitazone hydrochloride 56 Medication Adherence 56 Prevent Breast Cancer 55 Lowers Risk 55 investigational oral inhibitor 55 Dialysis Outcomes 55 Smoking Linked 55 orally administered synthetic retinoid 55 Enlarged Prostate 55 5 Fluorouracil 55 metformin sulfonylurea 55 Hormone Replacement 55 Preterm Labor 55 Randomized Evaluation 55 NCCN Updates 55 recurrent venous thromboembolism 55 Denufosol 55 Tocilizumab 55 Inhaled Nitric Oxide 55 Chemotherapeutic 55 FDA Approves Drug 55 PRoFESS 55 Coronary Disease 55 Lung Injury 55 somatostatin analog 55 recurrent glioblastoma multiforme 55 GISSI 55 opioid narcotic 55 Controlled Trial 55 Clinical Outcomes Utilizing Revascularization 55 Abciximab 55 ACTEMRA TM 55 Myocardial Infarction Study 55 CARE HF 55 Antitumor 55 Coronary Artery Bypass Graft 55 Relieve Depression 55 Excessive Sweating 55 unfractionated heparin UFH 55 Clinical Practice Guideline 55 Glucosamine Chondroitin Arthritis 55 Left Ventricular Dysfunction 55 Raloxifene Evaluation MORE 55 relapsed MM 55 Clinical Antipsychotic Trials 55 Eye Disease 54 abacavir lamivudine 54 Ischemic Events 54 evaluating picoplatin 54 Antiplatelet 54 Angiographic 54 Therapy Reduces 54 DVT prophylaxis cholesterol 54 Lipid Lowering 54 Bivalirudin 54 Prognostic Factors 54 Thromboembolic 54 oral rivaroxaban 54 MAGE A3 ASCI 54 Combo Therapy 54 Risedronate 54 Endologix Powerlink System 54 Anticoagulation 54 acute mania 54 Percutaneous Tibial Nerve Stimulation 54 Test Detects 54 Obesity Linked 54 Treatment Shows Promise 54 Cardiotoxicity 54 oral dihydropyrimidine dehydrogenase DPD 54 ATACAND 54 Acute Myocardial Infarction 54 sulindac 54 Anticonvulsant 54 MADIT II 54 * olmesartan medoxomil 54 Regimens 54 DU #b 54 RECORD1 54 inhibit platelet function 54 noninvasive outpatient 54 β blockers 54 Edge STudy 54 Glycemic Control 54 Muscle Function 54 NCT# ClinicalTrials.gov 54 II Clinical Trial 54 Atypical Antipsychotic 54 Aggressive Drug Evaluation 54 Hepatitis C Infection 54 Guaifenesin 54 Chemoprevention 54 Trandolapril 54 Thiazolidinediones 54 Primary endpoints 54 Hip Fractures 54 Reduces Breast Cancer 54 Diabetic Patients 54 rosuvastatin Crestor 53 Multidrug 53 Stress Induced 53 Metabolic Efficiency 53 Pre Exposure Prophylaxis 53 NSABP B 53 CLARITY TIMI 53 Squamous Cell 53 Antidepressants Linked 53 CIMZIA TM certolizumab pegol 53 arterial thrombosis 53 glucocorticoid induced osteoporosis 53 Preterm Delivery 53 Randomized controlled 53 NATRECOR ® 53 Nonsurgical 53 Helps Smokers Quit 53 antithrombotic therapy 53 Chronic Sinusitis 53 Chronic Lung 53 Multicenter Study 53 Causes Symptoms 53 RE LY ® 53 Randomized Clinical Trial 53 anticoagulant warfarin 53 #:#-#,# [003] 53 Gastric Cancer 53 Observational Study 53 atherogenic dyslipidemia 53 colorectal adenoma 53 alkylating agent 53 IMPACT DCM 53 aspirin clopidogrel 53 FDA Warns Against 53 BRIM2 53 hydroxocobalamin 53 postoperative AF 53 Secondary Endpoints 53 patients undergoing percutaneous 53 AIR CF1 53 Prostate Cancer Risk 53 Angiotensin receptor blockers 53 RE LY 53 multicenter multinational 53 antiplatelets 53 Phase III multicenter 53 Pain Relievers 53 Gene Mutation Linked 53 venlafaxine XR 53 ARIXTRA 53 #:#-#,# [002] 53 cilostazol 53 OAB overactive bladder 53 Thyroid Hormone 53 Visceral Fat 53 polyarticular 53 Hydroxyurea 53 Enzastaurin 53 Inhaled nitric oxide 53 adenoma recurrence 53 Lovastatin 53 NMDA antagonist 53 Pharmacotherapy 53 xanthine oxidase inhibitor 53 Heart Failure Trial 53 Chronic Heart Failure 53 ACCOMPLISH 53 Sipuleucel T 53 cardiovascular morbidity 53 Gum Disease 53 TDF FTC 53 Patency 53 multicenter randomized 53 TAXUS ATLAS 53 ANCHOR trial 53 Vaccine Shows Promise 53 Less Invasive 53 Polyp Prevention Trial 53 targeted radiotherapeutic 53 Childhood Asthma 52 BENICAR HCT 52 Intervention Trial 52 variceal bleeding 52 Placebo controlled 52 Arterial Disease 52 Cholesterol lowering 52 Beta Blockers 52 deferiprone 52 Antiviral Therapy 52 Laryngeal Cancer 52 Telmisartan 52 Diabetes Interventions 52 selective estrogen receptor modulators 52 Autoimmune Disease 52 superficial bladder cancer 52 ACUITY trial 52 Minimally Invasive Treatment 52 Captopril 52 statins cholesterol lowering 52 REALITY Trial 52 salmeterol fluticasone 52 Skin Disorders 52 glatiramer acetate 52 H2 receptor antagonists 52 Androgen deprivation therapy 52 ORACLE MS 52 G CSFs 52 Respiratory Infections 52 dyslipidaemia 52 H2 receptor antagonist 52 riociguat 52 Intervention Trial GAIT 52 endothelin antagonists 52 EnteroMedics proprietary neuroblocking technology 52 Improve Diagnosis 52 Acute Stroke 52 Insulin Sensitivity 52 statin cholesterol lowering 52 Coronary Angiography 52 Catheter Related Bloodstream Infections 52 KRN# 52 Anticholinergic 52 ILLUSTRATE 52 prospective randomized placebo 52 randomized multicenter trial 52 Frova ® 52 Improve Patient Outcomes 52 prospective multicentre 52 CAMMS# 52 prospective randomized controlled 52 secondary efficacy endpoint 52 Critically Ill Patients 52 Randomised 52 Guidelines Issued 52 Antiarrhythmic 52 Chronic Lyme Disease 52 morphometric vertebral fractures 52 blinded randomized placebo controlled 52 Chronic Obstructive Lung 52 Multi Ethnic Study 52 Migraine Headache 52 rFVIIa 52 multicenter randomized placebo controlled 52 AIR CF2 52 ß blockers 52 Myocardial Infarction 52 insulin sensitizing 52 Truvada tablets 51 Autoimmune Diseases 51 Val HeFT 51 CNS depressant 51 HCV SPRINT 51 Dry Powder Inhalers 51 TRANSFORMS 51 multicentre randomized controlled 51 Mindfulness Based Cognitive Therapy 51 oral anti arrhythmic 51 Xelox 51 velafermin 51 designated HVTN 51 HYVET 51 CINQUIL 51 IFN alpha XL 51 Febrile Neutropenia 51 Neglected Disease 51 Multiethnic Study 51 APTIVUS r 51 Sinus Infections 51 Lifestyle Intervention 51 Cynthia Sass Rodale Books 51 Topical Treatment 51 AIM HIGH 51 Intervention Effectiveness CATIE 51 phase Ib 51 ASTEROID 51 XIENCE V demonstrated 51 aldosterone antagonists 51 antiinflammatory drugs 51 ENDEAVOR IV 51 Prostate Cancer Prevention 51 Helicobacter pylori eradication 51 Thrombolysis 51 Fibromyalgia Pain 51 Degarelix 51 ONTARGET 51 symptomatic hyponatremia 51 ritonavir boosted 51 Combination therapy 51 prospective observational 51 peripherally acting 51 Biological Effects 51 Endovascular Valve Edge 51 PRADAXA 51 hepatic insufficiency 51 Immune Mediated 51 Clostridium Difficile Associated 51 Schizophrenia Treatment 51 Blood Thinning 51 topiramate Topamax 51 noscapine 51 endoluminal stent graft ELG 51 Doxil ® 51 MRSA Infections 51 Deep Venous Thrombosis 51 oral anticoagulant 51 Antiviral Drugs 51 prospectively stratified 51 Early Diagnosis 51 Ovary Removal 51 AVERROES 51 macrovascular 51 Neuromuscular Disorders 51 angiotensin II receptor blockers 51 H2 antagonists 51 TOHP 51 paricalcitol 51 venous thromboembolism VTE prophylaxis 51 AIR2 Trial 51 rosuvastatin 51 Preterm Birth 51 HCV RESPOND 2 51 inhaled formulation 51 Drug Coated Stents 51 Overactive Bladder OAB 51 HIV HCV coinfected 51 orally administered inhibitor 51 registrational Phase 51 multicenter placebo controlled 51 systemic immunosuppressive drugs 51 Proton Pump Inhibitors 51 Nicotine Addiction 51 active comparator 51 Detection Evaluation 51 phase IIIb 51 Efficacy 51 Pharmacologic 51 multicenter randomized clinical 51 invasive candidiasis 51 dose escalation clinical 51 Dabigatran 51 related CMV Retinitis 51 NATRECOR R 51 severe renal insufficiency 51 ACTIVE W 51 Colorectal Screening 51 nonrandomized 51 Unintended Pregnancy 50 Chronic Renal Failure 50 BRIM3 50 Endarterectomy 50 Clin Trials 50 CRESTOR rosuvastatin calcium 50 Cetrorelix pamoate 50 Perforomist ™ Inhalation Solution 50 Childhood Overweight 50 Study AREDS 50 RE MODEL 50 Evaluation WISE 50 Bystolic nebivolol 50 Robotic Assisted 50 Vaccine Prevents 50 injectable investigational 50 MEND CABG 50 Bloodstream Infections 50 Etiology 50 Cardiac Angiography 50 Pain Medication 50 Treating Prostate Cancer 50 Therapeutic Intervention 50 LUX Lung 50 relapsing multiple sclerosis 50 aldosterone antagonist 50 Prostate Screening 50 opioid induced bowel dysfunction 50 Stenting Trial 50 Complications Trial 50 Diabetes Complications 50 anticholinergic agents 50 forodesine 50 nonsteroidal anti inflammatories 50 insulin secretagogue 50 relapsing remitting MS RRMS 50 placebo controlled trials 50 symptomatic VTE 50 sorafenib Nexavar 50 angiotensin II receptor blocker 50 assessing T DM1 50 Hazardous Drugs 50 Osteoarthritis Pain 50 CALGB # [001] 50 Factor Xa inhibitor 50 investigational oral 50 DAPT 50 recurrent prostate cancer 50 icatibant 50 Acute GVHD 50 Experimental Vaccine 50 Prophylaxis 50 fosbretabulin 50 Prospective Randomized Trial 50 Outcome Measures 50 Viral Infections 50 upper endoscopy 50 R bisoprolol Euthyrox 50 Viread tenofovir disoproxil fumarate 50 neuropathy sparing 50 Non Melanoma Skin 50 mg BID dose 50 symptomatic BPH 50 Clostridium difficile Associated 50 CYP#A# inhibitors 50 Acute Decompensated Heart Failure 50 Metabolic Disorders 50 herpetic keratitis 50 Inhaled Steroids 50 Gastrointestinal Oncology 50 oral ridaforolimus 50 chromium supplementation 50 efavirenz EFV 50 Related Cancers 50 NCCTG N# 50 tPA antithrombotics anticoagulation therapy 50 angiotensin receptor blocker 50 prospective nonrandomized 50 mTOR inhibitor 50 metformin sulfonylureas 50 EmbraceAC 50 multi kinase inhibitor 50 ZOLINZA 50 IMiDs R 50 treatment naive genotype 50 prospective multicenter study 50 topical calcineurin inhibitors 50 Prove Effective 50 Reduce Unnecessary 50 chemosensitizer 50 Randomized Study 50 multicentre randomized 50 Valproic acid 50 clinically contraindicated 50 blinded randomized 50 CYPHER R Sirolimus eluting 50 immunosuppressive regimen 50 LIFELONG HEALTH 50 tibolone 50 Hematologic Malignancies 50 TNF alpha antagonist 50 LATUDA 50 candesartan 50 Hospitalized Patients 49 Rotavirus Vaccines 49 eosinophilic asthma 49 HDL Selective Delipidation 49 Stenting Trial CREST 49 abacavir Ziagen 49 RAPAFLO R 49 EVEREST II 49 antiangiogenic agent 49 drug zotarolimus 49 Acute Pain 49 non resectable 49 TRITON TIMI 49 Herbal Supplements 49 anthracycline unless 49 protease inhibitor PI 49 APPRAISE 49 NR2B selective 49 selenium supplementation 49 CLARITY study 49 Seasonal Influenza Vaccine 49 ENGAGE AF TIMI 49 parecoxib 49 adjunct therapy 49 #:# randomization 49 QD dosing 49 EURIDIS 49 Combination Therapies 49 Pediatric Psychopharmacology 49 CHAMPION PCI 49 postmenopausal osteoporotic women 49 randomized controlled clinical 49 landmark ATHENA 49 basal bolus regimen 49 multicentric 49 GISSI HF 49 mixed hyperlipidemia 49 desvenlafaxine succinate 49 Systematic Reviews 49 MADIT 49 Biochemical Pharmacology 49 Randomized 49 mycophenolate mofetil 49 antiarrhythmic drug 49 Bone Marrow Transplants 49 placebo controlled studies 49 teriflunomide 49 Dose escalation 49 metformin XR 49 Sentinel Lymph Node 49 #mg BID [001] 49 double blinded randomized 49 GI Disorders 49 beta blocker therapy 49 composite endpoint 49 nab paclitaxel 49 dietary modification 49 immunotherapeutic vaccine 49 Hospitalization Rates 49 ADMIRE HF 49 evaluating MGCD# [002] 49 Peanut Allergy 49 thetreatment 49 multicenter randomized controlled 49 BCIRG 49 visilizumab 49 Medidur ™ FA 49 serotonin norepinephrine reuptake inhibitors 49 thienopyridines 49 Cardio Vascular Disease 49 Prostate Cancer Screening 49 Cost Effectiveness 49 everolimus eluting stents 49 masked placebo controlled 49 SORT OUT III 49 Allergies Asthma 49 pharmacokinetics PK 49 TAXUS VI 49 Phase Ib II 49 Digital Mammographic Imaging 49 chemoradiation therapy 49 TMC# C# 49 WHEL 49 pharmacodynamics PD 49 subanalysis 49 HPV Vaccine Gardasil 49 undergone radical prostatectomy 49 Left ventricular hypertrophy 49 HORIZONS AMI 49 Solzira ™ 49 GOUT 49 maximally tolerated lipid lowering 49 phase IIb clinical 49 Mammography Screening 49 multicenter phase 49 Spine Patient Outcomes 49 estrogen receptor antagonist 49 PREZISTA r 49 pharmacodynamic effects 49 idraparinux 49 MERLIN TIMI 49 liposomal amphotericin B 49 Antifungal 49 recurrent malignant glioma 49 randomized Phase IIb 49 undergoing coronary angiography 49 ADVANCE PD 49 Epidemiological Studies 49 oral FTY# 49 Papillomavirus 49 stage IIIb IV 49 developed preclinically 49 Childhood Immunizations 49 ENLIGHT 49 treating abdominal aortic 49 atazanavir ritonavir 49 Multicenter 49 PEGylated interferon 49 randomized multicenter 49 oral PrEP 49 recurrent glioma 49 Could Save Lives 49 ziprasidone 49 multicenter Phase 49 BOLDER II 49 androgen suppression 48 immunomodulator 48 Subgroup analysis 48 Secondhand Smoke Exposure 48 maximally tolerated 48 Prophylactic 48 Asthma Attacks 48 Hepatitis Virus 48 Watchful Waiting 48 metastatic HRPC 48 label multicenter Phase 48 Phase 1b trial 48 ZACTIMA 48 Spectrum Disorders 48 double blinded placebo 48 EMBEDA TM 48 SPIRIT III 48 unstable angina UA 48 canakinumab 48 antiretroviral naive 48 multicenter Phase III 48 Postherpetic Neuralgia 48 blinded placebo controlled 48 Cigarette Smoking 48 Muscle Wasting 48 Prescription Painkiller 48 Cochrane Database 48 confirmatory clinical 48 Drug Combinations 48 Therapy HAART 48 placebo controlled Phase 48 LEXIVA r 48 Involuntary Exposure 48 adenotonsillectomy 48 pharmacologically active isomer 48 Left Atrial 48 PCI percutaneous coronary 48 anti arrhythmic drug 48 prospective randomized multicenter 48 landmark ATHENA trial 48 tolerability pharmacokinetics 48 factor Xa inhibitor 48 boosted protease inhibitor 48 EGFR tyrosine kinase inhibitor 48 Pesticide Exposure 48 Cardiac Arrhythmia 48 Pediatric Asthma 48 Pregnancy Outcomes 48 ABC/3TC 48 Antiretroviral 48 Aethlon Medical Announces 48 glycoprotein GP IIb IIIa 48 Group RTOG 48 multicentre randomized double 48 placebo controlled randomized 48 Hormonal Therapy 48 Alpha Tocopherol Beta Carotene 48 carotid artery stenting CAS 48 T1DM 48 Nanoemulsion 48 retrospective observational study 48 Lopinavir ritonavir 48 randomized clinical 48 pegylated interferon alfa 2b 48 Methotrexate MTX 48 Melanoma Skin Cancer 48 erythropoietic 48 Vaccine Protects Against 48 Overtreatment 48 Diabetes Digestive 48 endovascular stent graft 48 MIST II 48 pertuzumab 48 Clinical Practice Guidelines 48 Screening Trial 48 prospective observational cohort 48 immunomodulating 48 REVIVE Diabetes 48 Adolescent Substance Abuse 48 Pneumonia Vaccine 48 noninfectious uveitis 48 Intermittent Preventive Treatment 48 Interventional Procedures 48 Gynecological Cancer 48 Bacterial Infections 48 sapropterin dihydrochloride 48 Anesthetics 48 prospective multicenter randomized 48 journal Pharmacology Biochemistry 48 substudy 48 interferon ribavirin 48 ToGA 48 Mass Atrocities 48 Can Save Lives 48 Pharmacoepidemiology 48 CombAT 48 Smallpox Vaccination 48 RISPERDAL ® 48 REOPRO 48 FAMILY DOCTOR 48 Antiviral Drug 48 alefacept 48 mg administered orally 48 Clinical Gerontology 48 Mercury Fillings 48 multicenter Phase II 48 Arthritis Musculoskeletal 48 Cardiovascular Disease Epidemiology 48 CYCLOSET 48 direct renin inhibition 48 acid suppressant 48 Developmental Origins 48 Screening Mammography 48 SABCS 48 pain palliation 48 multicenter randomized double 48 dyskinesia PD LID 48 RoACTEMRA 48 Anti Retroviral 48 factor TNF receptor 48 noninferior 48 risperidone Risperdal 48 Procedures Bomb Threats 48 Neoplasia 48 carotid endarterectomy CEA 48 tricyclic 48 factor TNF 48 Venous Thromboembolism VTE 48 antiarrhythmic 48 NCI Cancer 48 orally inhaled 48 Phase IIA 48 injectable urethral bulking 48 periprocedural MI 48 gastro esophageal reflux disease 48 Colesevelam 48 Systematic Treatment 48 FOSRENOL R 48 Reduce Health Disparities 47 BR.# 47 phase IIa 47 Ventilator Associated 47 ibandronate 47 pegylated liposomal doxorubicin 47 Wisconsin Sleep Cohort 47 antiinflammatory 47 #mg/day [001] 47 bosentan 47 CORD II 47 Merck Suspends Lobbying 47 Percutaneous Coronary Interventions 47 SCAI Annual 47 developing Zerenex ferric 47 corrected QT interval 47 Doctors Warn 47 Drug Interaction 47 Stereotactic Radiosurgery 47 PRE SURGE 47 Hospital Readmissions 47 Defense Congressionally Directed 47 clopidogrel pretreatment 47 Racial Disparities 47 Torisel 47 ALLHAT 47 randomized controlled trial 47 nondiabetic patients 47 adjunctively 47 Childhood Blindness 47 iliac artery disease 47 ACOSOG Z# 47 Vitamin D Deficiency 47 SomatoKine 47 Rifampicin 47 Fracture Intervention Trial 47 trials RCTs 47 Psychodynamic Psychotherapy 47 Anti Angiogenesis 47 Bruce Psaty 47 bupropion SR 47 Counterfeit Drugs 47 oral proteasome inhibitor 47 Early Lung Cancer 47 opioid receptor antagonist 47 buprenorphine naloxone 47 IONSYS TM 47 Drug Resistant Tuberculosis 47 CANCIDAS 47 placebo controlled Phase III 47 Whooping Cough Vaccine 47 Antibiotic Resistant 47 Cellulite Reduction 47 randomized multicenter Phase III 47 Phase #/#a 47 prucalopride 47 lipid lowering therapy 47 Protein Involved 47 Cardiovascular Imaging 47 BoNTA 47 Prostate Lung Colorectal 47 Am J Manag 47 ASCEND HF 47 Women Ischemia Syndrome 47 Neurological Diseases 47 CORTOSS R 47 bevacizumab Avastin 47 Medication Errors 47 antiretroviral naïve 47 placebo controlled clinical 47 prospective observational studies 47 Childhood Brain Tumor 47 osteoporotic vertebral compression fractures 47 VFEND 47 Needlestick Safety 47 phase IIb trial 47 Screening Trial DMIST 47 patients undergoing CABG 47 Stroke Prevention 47 Pneumococcal Disease 47 Anti Fungal 47 ENESTnd 47 sirolimus eluting stents 47 controlled multicenter 47 standard chemotherapy regimen 47 neoadjuvant treatment 47 Smallpox Vaccine 47 Adjunct Clinical 47 Lipoproteins 47 Male Impotence 47 thromboprophylaxis 47 APEX AMI trial 47 Periodontal Diseases 47 SPIRIT FIRST 47 transurethral resection 47 Chronic Illnesses 47 HF ACTION 47 longitudinal observational study 47 investigational atypical antipsychotic 47 retrospective cohort study 47 HeFT 47 Surgical resection 47 analgesic efficacy 47 adjunctive treatment 47 Fat Grafting 47 statin therapy 47 ECASS 47 APTIVUS 47 Lenocta TM sodium stibogluconate 47 ID NCT# 47 Bone Density 47 Heroin Addiction 47 R palivizumab 47 multicentre prospective 47 COPD inhalation anthrax 47 potent topoisomerase II 47 antimuscarinic agent 47 Comparative Effectiveness 47 pyridostigmine 47 vitamin D supplementation 47 Prevent Carbon Monoxide 47 Helicobacter Pylori 47 RE LY trial 47 Colorectal Cancer Screening 47 Angiox R 47 Non Communicable Diseases 47 pimecrolimus cream 47 FFNS 47 Clot busting 47 homocysteine lowering 47 transdermal estrogen 47 Molecular Pathogenesis 47 Neonatal Resuscitation 47 Psychotropic Drugs 47 reversing heparin 47 demethylating agents 47 Racial Disparity 46 #mg dose [003] 46 SSRI citalopram 46 prospectively randomized 46 Sequenced Treatment Alternatives 46 Surgical excision 46 SIMPADICO 46 Brady Handgun Violence 46 oral anticoagulation 46 partial opioid agonist 46 REYATAZ ritonavir 46 duplex ultrasonography 46 Herpes Zoster 46 levocetirizine 46 Acute Coronary Syndromes ACS 46 tipranavir 46 Fibrin Pad 46 Phase III randomized 46 strontium ranelate 46 Prevention CDC Morbidity 46 ginkgo biloba extract 46 Bipolar Disorders 46 Phase IIB 46 dexpramipexole 46 metreleptin 46 neoadjuvant 46 Impotency 46 observational cohort 46 PRECISE 46 antiplatelet therapy 46 Polypharmacy 46 Pediatric Rheumatology 46 RSD# oral 46 CRESTOR #mg 46 Pilocarpine 46 Aortic Aneurysms 46 genital human papillomavirus 46 quadrivalent HPV vaccine 46 Otitis Media 46 histone deacetylase inhibitor 46 anti secretory 46 Prenatal Screening 46 bronchodilator therapy 46 REVLIMID lenalidomide 46 nonpharmacological 46 Tobacco Hazards 46 eprotirome 46 Infect Control 46 NO# [002] 46 ACCORD Lipid 46 irreversible inhibitor 46 Cardiac Disease 46 investigational oral antiplatelet 46 pramlintide metreleptin combination 46 arteriography 46 prospectively defined 46 LCP AtorFen 46 antitumor effect 46 Phase IIIb 46 patientswith 46 Pressure Ulcer 46 XIENCE V Stent System 46 Multicentre 46 viral kinetics 46 anti hypertensives 46 oral transmucosal 46 meta regression 46 Medication Error 46 randomized Phase III 46 Craniofacial Surgery 46 Fibrostat R 46 Cardiac Arrest Patients 46 PREVENT IV 46 quinacrine 46 agomelatine 46 adalimumab 46 darunavir r 46 RG# ITMN 46 Adenoscan R 46 Oral Abstract 46 LUC Stritch School 46 HOPE TOO